Chemical Name: (4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline hydrochloride
Purity: ≥98% (HPLC)
Biological Activity
Technical Data
Solubility
Calculators
Datasheets
References
Biological Activity
Selective dopamine D2 receptor agonist (Ki values are 4.8, ~24, ~30 and 1900 nM at D2, D3, D4 and D1 receptors respectively).
Licensing Information
Sold with the permission of Eli Lilly and Company
Compound Libraries
(-)-Quinpirole hydrochloride is also offered as part of the
Tocriscreen Plus. Find out more about compound libraries available from Tocris.
Technical Data
M. Wt
255.79
Formula
C13H21N3.HCl
Storage
Desiccate at -20°C
Purity
≥98% (HPLC)
CAS Number
85798-08-9
PubChem ID
55397
InChI Key
HJHVRVJTYPKTHX-HTMVYDOJSA-N
Smiles
Cl.[H][C@]12CCCN(CCC)[C@]1([H])CC1=CNN=C1C2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent
Max Conc. mg/mL
Max Conc. mM
Solubility
DMSO
6.39
25
water
25.58
100
Preparing Stock Solutions
The following data is based on the product molecular weight 255.79. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass
1 mg
5 mg
10 mg
1 mM
3.91 mL
19.55 mL
39.09 mL
5 mM
0.78 mL
3.91 mL
7.82 mL
10 mM
0.39 mL
1.95 mL
3.91 mL
50 mM
0.08 mL
0.39 mL
0.78 mL
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets
Certificate of Analysis / Product Datasheet
Safety Datasheet
Select another language:
View SDS
References
References are publications that support the products' biological activity.
Levantet al (1996) Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J.Pharmacol.Exp.Ther. 278 145 PMID: 8764345
Seeman and Van Tol
(1994) Dopamine receptor pharmacology. Trends Pharmacol.Sci. 15 264 PMID: 7940991
Sullivanet al (1998) Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats. Neuroscience 83 781 PMID: 9483561